Navigation Links
Ruminson Astigmatic Gauge & Marker

ProductsRuminson Astigmatic Gauge & Marker
Company RGP Medical
Item Ruminson Astigmatic Gauge & Marker
Features 
Description Gauge Measures 360 Degrees & Can Be Set To Any Degree Interval For Marking On A Cornea. 7mm Inner Diameter & 14mm Outer Diameter Opposing Radials Accommodate All Astigmatic Incisions.

The Only Astigmatism Gauge That Can Be Set For AKs, LRIs Or Peripheral Corneal Incisions At Any Degree Around The Globe.

Marks Single Or Paired AKs, LRIs Or Peripheral Corneal Incisions 360 Degrees, At Any Axis.

Cut-Outs At Each 90 Degree Meridian Allow Visualization Of The Limbus For Easy Centering On The Eye.

The Gauge Corresponds To Phoropter & Keratometer Readings, And Can Be Easily Set By A Technician.

Reusable, Autoclaveable, Made In The USA, & Available For A Surgical Evaluation Without Obligation.

Info RGP Medical
Customer Service: (800) 522-9695
Web site: http://www.rgpergo.com

Related medicine products :

1. Newman Astigmatic Micrometer Knife
2. Diamond Knives for Astigmatic & Radial Keratotomy
3. Knolle Lens Nucleus Spatula and Anterior Chamber Gauge
4. Nichamin Fixation Ring and Gauge
5. Silicone Oil Cannula System - 20 Gauge
6. Silicone Oil Cannula System - 19 Gauge
7. Disposable Bipolar Pencil - 18 Gauge Curved
8. Disposable Bipolar Pencil - 18 Gauge Straight
9. Disposable Bipolar Pencil - 23 Gauge Tapered Tip
10. Retinal Hydrodissection Cannula 41 Gauge I.D.
11. 27 Gauge Air Injection Cannula
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products:
(Date:10/22/2014)... Your Body’s Way , In a world where a multi-billion-dollar ... can be difficult to choose the right weight loss method. ... it the healthy way? Set aside the fads and resist ... regularly, and choose foods with the most nutritional benefits. ... exercise more and eat less. Despite the number of advertisements ...
(Date:10/22/2014)... Mission Viejo, CA (PRWEB) October 22, 2014 ... that Jay Cormier, Sr. Vice President of Sales, will ... at the upcoming Meetings Technology Expo on October 28, ... will also be hosting a booth as well as ... on how Lintelus Meeting can create a more engaging ...
(Date:10/22/2014)... Akeso Biomedical, Inc. , a privately held ... infections, microbial biofilms, and chronic wounds, announced that Dr. ... , Dr. Sinskey is a Professor ... of Technology, or MIT. He has been a member ... holds positions as Co-Director of the Malaysia-MIT Biotechnology Partnership ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, ... (IVF) are only about half as likely as white women ... research indicates, and the racial disparity persists even when donor ... of white patients became pregnant after IVF, compared to about ... IVF cycles over two years to tease out the impact ...
(Date:10/22/2014)... By Tara Haelle ... -- Binge drinking among young adult men may lead to ... binge drinking didn,t cause a similar rise in blood pressure ... study. In fact, when young adult women drank lightly or ... half, the study found. "This finding parallels studies in ...
Breaking Medicine News(10 mins):Health News:ReductionGuruMD Presents Ways to Improve Your Weight Loss Results 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4
... sleep loss and sleep disorders to health problems such ... The latest findings in sleep research will be presented ... specialists when the SLEEP 2011 25th Anniversary Meeting of ... Minneapolis Convention Center from June 13 to 15. ...
... (HealthDay News) -- Newly proposed national standards for mercury, ... could prevent as many as 17,000 premature deaths and ... Environmental Protection Agency. The proposed standards, released Wednesday ... could also prevent 120,000 cases of childhood asthma symptoms ...
... March 16 (HealthDay News) -- Young adults are more likely to ... at an early age and also had to cope with stressful ... a study that included 166 women and 140 men in Germany ... any stressful life events in the previous three years, what daily ...
... This release is available in French . ... research projects on regenerative medicine and nanomedicine received $16 million ... Health Research (CIHR) and the Canadian Space Agency (CSA), were ... Carrie, Member of Parliament for Oshawa; Dr. Jane Aubin, Scientific ...
... difficult: standing with a walker or cane in the voting ... or trying to punch the tiny button to vote for ... process leaves many seniors disenfranchised, particularly for residents of long ... a process called mobile polling where election officials register ...
... HealthDay Reporter , TUESDAY, March 15 (HealthDay News) ... on cell phones while crossing the street, because new ... group than for college students. In laboratory simulations ... 59 to 81 and 18 undergraduates aged 18 to ...
Cached Medicine News:Health News:EPA Proposes Tougher Air Pollution Rules for Power Plants 2Health News:Drinking Behavior May Be Tied to Early Alcohol Use 2Health News:Important funding for nanomedicine research to improve diagnosis and treatment 2Health News:Important funding for nanomedicine research to improve diagnosis and treatment 3Health News:Rocking the vote from rocking chairs 2Health News:Crossing Street While on Cell Phone Risky for Seniors 2
(Date:10/22/2014)... Va. and AUSTIN, Texas ... Inc. and PureMHC LLC today announced they have ... develop novel antibody-based immunotherapies designed to target cancers. ... of phosphorylated peptides displayed on the surfaces of ... phosphopeptide tumor targets (PTTs), derived from proteins that ...
(Date:10/22/2014)... Oct. 22, 2014  Regulus Therapeutics Inc. ... company leading the discovery and development of ... it has demonstrated human proof-of-concept with a ... evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting ... C virus infection ("HCV").  Interim results from ...
(Date:10/20/2014)...  Indianapolis interventional medical device maker NICO ... 3D visualization leader Synaptive Medical announced ... Meeting that they have joined forces to integrate ... is the first of its kind and will ... NICO,s BrainPath® interventional access technology and Synaptive,s BrightMatter™ ...
Breaking Medicine Technology:Biotech Companies To Co-Discover And Co-Develop Antibodies Targeting Novel Phosphopeptide Tumor Targets 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 2A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 3A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 4A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 5A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 6A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 7A Single Subcutaneous Dose of 2mg/kg of RG-101, Regulus' Wholly-Owned, GalNac-Conjugated anti-miR Targeting microRNA-122, Demonstrates 4.1 log10 Mean Viral Load Reduction as Monotherapy at Day 29 in Patients with Varied HCV Genotypes and Treatment H 8Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 2Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 3Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 4Indianapolis' NICO Corporation and Toronto's Synaptive Medical, Inc. Announce First-Ever Intervention-Visualization Partnership with Goal to Improve Standard of Care in Neurosurgery 5